Introduction {#sec1}
============

The self-assemblies of Ru(II)-based metallomacrocycles^[@ref1]^ are of considerable interest owing to their potential applications for drug delivery, molecular recognition, encapsulation catalysis, and molecular topology.^[@ref2]−[@ref6]^ Because of cytotoxic properties of Ru(II), there is great interest in Ru(II)-metallomacrocycles developing new systems for drug discovery programs.^[@ref7]^ In this regard, Ru(II)-based supramolecules, such as molecular rectangles, cages, and capsules, are important because they can be easily synthesized and have high nuclearity and also because of the synergistic effects of incorporated functionalities. Furthermore, chemical and physical properties, such as solubility, luminescence, and interactions with biomolecules, can be achieved by functionalization.^[@ref8]^ Our group and others have previously described the promising antiproliferative properties of Ru(II)-based metallomacrocycles.^[@ref9]^ Triazole is an important heterocyclic ring synthesized by Cu(I)-catalyzed azide-alkyne cycloaddition (the click reaction) and enables the incorporation of various functionalities in supramolecules.^[@ref10]^ Crowley and co-workers extensively studied the coordination chemistry of "click" complexes, which display a wide range of potential applications as catalysts and medicinal agents.^[@ref11]^ However, the anticancer activities of Ru(II)-metallomacrocycles containing the 4-pyridyl-1,2,3-triazole moiety have not been reported to date.

Worldwide, primary hepatocellular carcinoma (HCC) is the sixth most common malignancy and is the second cause of human death by cancer.^[@ref12]^ HCC is characterized by its high incidence rate in hepatitis B virus-associated cirrhotic liver disease and is known to be associated with hepatitis C virus infection, exposure to aflatoxin, sex, hormones, and some metabolic diseases.^[@ref13],[@ref14]^Apoptosis is a typical phenomenon of programmed cell death, implicated in cellular and physiological processes,^[@ref15],[@ref16]^ and is linked to cell cycle arrest and blockade of the cell cycle, which are regarded effective strategies for eliminating cancer cells.^[@ref17]^ Several apoptotic pathways have been identified to date, the most significant of which are the intrinsic mitochondria-mediated and the extrinsic pathways.^[@ref18]^ Furthermore, cell cycle-mediated apoptosis is attracting increasing attention because it may minimize the risk of acquired drug resistance and is associated with low mutagenicity and toxicity.^[@ref19],[@ref20]^ The mammalian cell cycle is positively regulated by cyclin-dependent kinases (Cdks), which associate to form heterodimeric complexes.^[@ref21]−[@ref24]^ Here, we report the synthesis, characterization, and anticancer activities of triazole-based Ru(II)-metallomacrocycles, which were produced during our on-going efforts to synthesized Ru(II)-based supramolecules for biological applications.

Results and Discussion {#sec2}
======================

Triazole-based dipyridyl ligand **L** containing 4-pyridyl-1,2,3-triazole moiety was prepared by the Cu(I)-catalyzed cycloaddition reaction (the click reaction) of 4-azidopyridine and 1,4-bis(ethynyl)anthracene in butanol/water (4:1) at 50 °C to give the desired click product in 80% yield ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Ligand **L** was found to be poorly soluble in common NMR solvents, such as nitromethane, methanol, and DMSO, and thus, characterization data was obtained in a CD~3~OD/CDCl~3~ (1:1) cosolvent mixture. Combined spectroscopic analysis of ligand **L** by electrospray ionisation mass spectrometry (ESI-MS), NMR spectroscopy, and elemental analysis confirmed its formation and the incorporation of the 4-pyridyl-1,2,3-triazole moiety into anthracene. Previous reports on "click ligands" have mainly focused on the 2-pyridyl-1,2,3-triazole moiety and its coordination with different metals. Using the above-mentioned synthetic method, various functionalities can be introduced and fine tuning of the properties of resulting complexes can be achieved. Furthermore, the anthracene moiety incorporated in ligand **L** has been utilized in arene-ruthenium metallomacrocycles for biological application.^[@ref25]^ Ligand **L** is designed in such a way that synergistic effects of functionalities incorporated can be utilized in anticancer activities.

![Synthesis of Triazole-Based Ligand **L**](ao-2019-00093e_0006){#sch1}

Reaction between ligand **L** and arene-Ru(II)-acceptors (**1**--**4**) in methanol or nitromethane resulted in \[2 + 2\] self-assembled macrocycles ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). The ^1^H NMR spectra of metallomacrocycles **5**--**8** are provided in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}. ^1^H NMR showed the \[2 + 2\] self-assembly of Ru(II)-acceptor with ligand **L**. The \[2 + 2\] self-assemblies of **7** and **8** were also confirmed in methanol solution (see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00093/suppl_file/ao9b00093_si_001.pdf)). Mass spectrometry (ESI-MS) confirmed the formation of metallomacrocycles **5--8**. The isotopic distributions of metallomacrocycle **5** at 512.8365 \[**5**-4OTf\]^4+^, of **6** at 766.7859 \[**6**-3OTf\]^3+^, of **7** at 800.1315 \[**7**-3OTf\]^3+^, and of **8** at 866.8110 \[**8**-3OTf\]^3+^ agreed with theoretical values (see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00093/suppl_file/ao9b00093_si_001.pdf)).

![^1^H NMR spectra of metallomacocycles **5**--**8** in nitromethane (conc. 8 mM).](ao-2019-00093e_0001){#fig1}

![Coordination-Driven Self-Assembly of Metallomacocycles **5**--**8**](ao-2019-00093e_0007){#sch2}

Finally, \[2 + 2\] self-assembly of metallomacrocycle **8** was confirmed by single-crystal X-ray diffraction studies ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). Suitable crystals of X-ray quality were obtained by the slowly diffusing diethyl ether into a solution of metallomacrocycle metallomacrocycle **8** in nitromethane. Macrocycle **8** crystallized in monoclinic space group *P*21/*n*. In crystal structure of **8**, anthracene moieties were displaced from the molecular plane by steric effects. Although ligand **L** can adopt two extreme (syn and anti) conformations, it adopted a pseudo-linear (anti) conformation with two 4-pyridyl-1,2,3-triazole moieties opposite each other. Crystallographic data and structure refinement parameters are provided in [Table S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00093/suppl_file/ao9b00093_si_001.pdf).

![Crystal structure of metallomacrocycle **8**. Counteranions and hydrogen atoms are omitted for clarity.](ao-2019-00093e_0002){#fig2}

Effects on Cancer Cell Growth {#sec2.1}
-----------------------------

The cancer cell growth inhibition test based on MTT-based assessments of mitochondrial activity is mainly used for drug screening and cytotoxicity testing.^[@ref26]^ We first assessed the cytotoxic potential of compounds **5**--**8** by determining their IC~50~ values in human cancer cells ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Metallomacrocycle **7** exhibited good anticancer potentials in AGS, HCT-15, and HepG2 cells. In addition, it was confirmed that the IC~50~ value in human normal cell (HEK293) was 35.7 ± 0.70 μM, which was not toxic at the experimental concentration.

###### Inhibitory Effects of Synthesized Triazole-Based Ru(II)-Metallomacrocycles and Doxorubicin (IC~50~, μM) on the Viabilities of Human Cell Lines

                    IC~50~ (μM)                                            
  ----------------- ------------- ------------- ------------ ------------- -------------
  **L**             \>20          \>20          \>20         \>20          \>40
  **5**             \>20          10.8 ± 1.61   \>20         14.3 ± 2.51   \>40
  **6**             \>20          16.5 ± 0.96   \>20         \>20          \>40
  **7**             11.9 ± 0.68   2.4 ± 0.15    1.8 ± 0.05   4.4 ± 0.45    35.7 ± 0.70
  **8**             7.5 ± 0.78    5.4 ± 0.87    8.2 ± 0.11   4.5 ± 0.19    28.3 ± 2.14
  **doxorubicin**   \<0.625       \<0.625       6.6 ± 1.26   3.6 ± 0.41    \>40

Stabilities of Metallomacrocycles 7 and 8 in Cell Culture Medium {#sec2.2}
----------------------------------------------------------------

Metallomacrocycles **7** and **8** were preincubated in cell culture medium at 20 μM for 0, 24, 48, or 72 h at 37 °C. These samples (0--20 μM) were treated on the cells for 24 h. The cell growth inhibition activities of metallomacrocycles **7** and **8** on HepG2 cells were determined by the MTT assay. The cell growth inhibition activity of metallomacrocycle **7** was stable for 48 h and then declined slightly over the next 24 h ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). The stability of AGS and HCT-15 cells decreased over time. Thus, further studies were conducted using HepG2 cells.

###### Stabilities of the Growth-Inhibitory Activities of Metallomacrocycles **7** and **8** in AGS, HCT-15, and HepG2 Cells

                        preincubation time (h)                               
  -------- ------------ ------------------------ ------------- ------------- -------------
  HepG2    7            2.0 ± 0.01               4.6 ± 0.34    6.9 ± 0.20    11.7 ± 0.83
  8        3.0 ± 0.27   4.3 ± 0.57               13.4 ± 2.18   \>20          
  AGS      7            2.1 ± 0.03               5.9 ± 0.16    13.6 ± 0.11   18.6 ± 0.34
  8        2.4 ± 0.33   7.6 ± 0.55               17.2 ± 1.10   \>20          
  HCT-15   7            4.3 ± 0.25               7.6 ± 0.16    16.9 ± 0.90   \>20
  8        7.1 ± 0.74   17.9 ± 0.74              \>20          \>20          

These results indicate that metallomacrocycle **7** is stable in cell culture medium and strongly inhibited cancer cell growth. Metallomacrocycle **8** stably inhibited cell growth for 24 h but failed to do so at 48 h. Accordingly, we conducted further evaluation of the anticancer effect of metallomacrocycle **7**. The stability in DMSO solution was also checked for macrocycles **7** and **8** by ^1^H NMR (see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00093/suppl_file/ao9b00093_si_001.pdf)). The stabilities of macrocycles **7** and **8** were determined in phosphate-buffered saline (PBS, pH 7.5) solution via UV--visible spectrophotometry. Macrocycles **7** and **8** are stable enough in PBS solution over 72 h as reveled by UV--visible spectra (see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00093/suppl_file/ao9b00093_si_001.pdf)).

Apoptosis in Metallomacrocycle 7-Treated HepG2 Cells {#sec2.3}
----------------------------------------------------

To determine whether the cytotoxic effect of metallomacrocycle **7** in HepG2 cells was mediated by apoptosis, cells were treated with metallomacrocycle **7** at concentrations from 0 to 10 μM for 24 h and DAPI staining was observed using a Tali image-based cytometer. As shown in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}, metallomacrocycle **7** markedly and concentration-dependently induced apoptosis, suggesting that it is selectively cytotoxic to cancer cells and that this is achieved by the induction of apoptotic cell death.

![Effect of metallomacrocycle **7** on apoptotic cell death. Notes: Evaluation of apoptotic HepG2 cells. Apoptotic cells show green fluorescence, necrotic cells show red and green fluorescence (observed as yellow), and live cells show little or no fluorescence. Apoptosis was quantified using a Tali image-based cytometer (Thermo Fisher Scientific). Values are expressed as mean ± SEM (*n* = 3). \**p* \< 0.05 vs control, \*\**p* \< 0.01 vs control.](ao-2019-00093e_0003){#fig3}

Metallomacrocycle 7-Induced Caspase Activation and Modulated Intrinsic Mitochondrial Apoptosis in HepG2 Cells {#sec2.4}
-------------------------------------------------------------------------------------------------------------

Apoptotic cell death pathways include the extrinsic death receptor pathway and the intrinsic mitochondria-mediated pathway.^[@ref27]^ Caspase 8 (a marker of the extrinsic death receptor pathway), caspase 9 (a marker of the intrinsic mitochondria-mediated pathway) are "initiator" caspases, whereas caspase 3 and caspase 7 are "effector" caspases.^[@ref28],[@ref29]^ To elucidate the molecular mechanism responsible for metallomacrocycle **7**-induced apoptosis, we examined the expressions of apoptosis-related proteins, caspases, and poly ADP-ribose polymerase (PARP) in HepG2 cells. Western blotting was used to measure caspase levels to evaluate the extrinsic apoptotic response to metallomacrocycle **7**. As shown in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}, the expressions of cleaved caspase 7 and caspase 3 were increased dose dependently and metallomacrocycle **7** caused the activation of PARP, as evidenced by a reduction in PARP and an accumulation of cleaved PARP. To evaluate the effect of metallomacrocycle **7** on the mitochondrial intrinsic pathway in HepG2 cells, we measured the protein levels of Bcl-2 proteins (Bcl-2, Bax, and Bid) and p53 after exposure to metallomacrocycle **7** at 0, 2.5, 5, and 10 μM. As shown in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}B, the protein levels of Bax, Bid, and p53 decreased and Bcl-2 expression did not change after exposure, indicating that these might not be the key molecules of metallomacrocycle 7-induced apoptosis. These results confirm that metallomacrocycle 7 in HepG2 cells induces apoptosis through the extrinsic pathway rather than the mitochondrial intrinsic pathway through p53 and Bax.

![Regulation of apoptotic cell death by metallomacrocycle **7**. HepG2 cells were treated with metallomacrocycle **7** at 0--10 μM for 24 h.](ao-2019-00093e_0004){#fig4}

Metallomacrocycle 7-Induced Cell Cycle Arrest in HepG2 Cells {#sec2.5}
------------------------------------------------------------

To clarify metallomacrocycle 7-induced inhibitory effects on HepG2 cell proliferation, the cell cycle phase distributions of HepG2 cells were examined by the Tali image-based cytometer. Cell cycle regulation provides an important means of inhibiting cancer growth,^[@ref30]^ and the initiation and regulation of cell cycle phases are achieved by complex signal transduction systems. In particular, the cyclin A/Cdk2 complex controls cell cycle progression from S phase to G2/M.^[@ref31]^ In addition, Rao et al.'s study showed that increasing p27 causes G1 arrest through inhibiting the binding of CDK and cyclin E/A in p53-independent pathways.^[@ref32]^[Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}A shows that incubation of metallomacrocycle 7 with HepG2 cells for 24 h significantly reduced the DNA content and makes them appear in the G~0~/G~1~ phase, which is an indicative of apoptosis, with a consequent loss of cells in the G~1~ phase; 44% of cells were gated in G~0~/G~1~ phase. To characterize metallomacrocycle **7**-induced G~0~/G~1~ phase arrest, we investigated changes in the expressions of cyclin and Cdk ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}B). We found that metallomacrocycle **7** treatment reduced cyclin A and E and Cdk 2, 4, and 6 expressions but increased cyclin D1 expression. Furthermore, metallomacrocycle **7** dose-dependently increased the protein levels of p16 and p27 (a tumor suppressor related to a variety of human cancers^[@ref33]−[@ref36]^ and a mediator of the activation of cyclin E/cyclin A-Cdk2 and, thus, of progression to the G~0~/G~1~ phase,^[@ref37],[@ref38]^ respectively).

![Regulation of cell cycle by metallomacrocycle **7**. HepG2 cells were treated with metallomacrocycle 7 at 0--10 μM for 24 h. (A) Cell cycle as measured using a Tali image-based cytometer. (B) Expression of proteins related to cell cycle as detected by western blot analysis.](ao-2019-00093e_0005){#fig5}

Experimental Section {#sec3}
====================

General Details {#sec3.1}
---------------

4-Azidopyridine, 1,4-bis(ethynyl)anthracene, and arene-ruthenium acceptors **1**--**4** were prepared according to literature procedures.^[@ref39],[@ref40]1^H and ^13^C NMR spectra were recorded on Bruker 300 and 400 MHz spectrometers, respectively. ^1^H NMR chemical shifts are reported relative to the residual protons of deuterated CD~3~OD (3.31 ppm) and CD~3~NO~2~ (4.33 ppm). ESI-MS spectra of metallomacrocycles were recorded on a Synapt G2 quadrupole time-of flight mass spectrometer equipped with an electrospray ion source (Waters, Milford, MA) and analyzed using the MassLynx software suite system at the Korea Basic Science Institute (Ochang). Phosphate-buffered saline (PBS, pH 7.5; Sigma-Aldrich) solution was used as received. The sample for UV--vis absorption was prepared by dissolving macrocycles with a minimum amount of CH~3~OH followed by dilution with phosphate-buffered saline solution (18 μm, 25 mL). The spectra were recorded using a Varian Cary-100 UV--vis spectrophotometer.

### Single-Crystal X-ray Diffraction {#sec3.1.1}

Intensity data of suitable crystals of **8** were collected at 100 K on an ADSC Quantum 210 CCD diffractometer using synchrotron radiation (λ = 0.70000 Å) at the Supramolecular Crystallography Beamline 2D, Pohang Accelerator Laboratory (PAL; Pohang, Korea). Raw data was integrated and scaled using HKL3000. The structure of **8** was solved using direct methods,and refinements were carried out by the full-matrix least-squares method on *F*^2^ using appropriate software implemented in the SHELXTL program package.^[@ref41]^ Hydrogen atoms were added to their geometrically ideal positions and were refined anisotropically. Most disordered solvent molecules were removed from the diffraction data using the SQUEEZE routine in PLATON software,^[@ref42]^ and final refinements were then conducted. X-ray crystallographic data is provided in [Table S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00093/suppl_file/ao9b00093_si_001.pdf).

Cell Culture {#sec3.2}
------------

AGS (human gastric adenocarcinoma), HCT-15 (human colorectal carcinoma), A549 (human lung carcinoma), HepG2 (human hepatocellular carcinoma), and HEK293 (human embryonic kidney cells) cells lines were obtained from the American Type Culture Collection (ATCC, Manassas, VA). A549, AGS, HCT-15 cells were cultured in RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS, Gibco) and 1% penicillin/streptomycin (P/S, Gibco). HepG2 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS and 1% P/S. HEK293 cells were cultured in MEM medium supplemented with 10% FBS, 1% P/S, and 25 mM HEPES. All cell lines were cultured in a 5% CO~2~ incubator at 37 °C. The human cell lines used were handled in accordance with human cell line experimental guidelines.

Cancer Cell Growth Inhibition Assay {#sec3.3}
-----------------------------------

Human cancer cells were seeded into 96-well plates at ∼5 × 10^3^ cells per well, incubated at 37 °C overnight, and then treated with compounds dissolved in dimethyl sulfoxide (DMSO, final concentration 0.4%) in a 5% CO~2~ atmosphere for 24 h at 37 °C. After these treatments, cells were treated with 10 μL of MTT (3-\[4,5-dimethylthiazol-2-yl\]-2,5-diphenyltetrazolium bromide) solution in a 5% CO~2~ atmosphere for 4 h at 37 °C. The formazan formed was dissolved in 100 μL of DMSO, and the absorbance was measured at 550 nm using a multireader (TECAN, Switzerland). Half-maximal inhibitory concentration (IC~50~) values were defined as the concentrations that inhibited cell viability by 50%.

Tali Image-Based Cytometric Assay {#sec3.4}
---------------------------------

Apoptosis was assessed using a Tali image-based cytometer (Invitrogen), as previously described.^[@ref43]^ HepG2 cells were seeded at 2 × 10^5^ cells/mL in 6-well plates and 24 h later treated with different concentrations of metallomacrocycle **7** (0--10 μM) in a 5% CO~2~ atmosphere for 24 h at 37 °C. Cells were harvested using the trypsin/EDTA (T/E, Gibco) reagent and stained with the Tali apoptosis kit. Cells were stained with annexin V---Alexa Fluor 488 conjugate to quantify apoptotic cells. Propidium iodide (PI) was used to differentiate necrotic and apoptotic cells. Percentages of live, apoptotic, and necrotic cells as determined using the Tali cytometer were comparable with those obtained by flow cytometry.

Western Blot Assay {#sec3.5}
------------------

HepG2 cells (1 × 10^6^ per 60 mm dish) were plated in dishes and allowed to attach for 24 h. After metallomacrocycle **7** treatment, cells were washed with cold PBS, harvested, and cell pellets were lysed with the protein extraction solution (iNtRON, Korea) on ice for 1 h. Proteins were separated by centrifugation at 12 000 rpm for 10 min at 4 °C, and aliquots (40 μg) were separated by 12% sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE) electrophoresis and then transferred onto nitrocellulose membranes (Bio-Rad Laboratories Inc., Hercules, CA). Nonspecific binding was blocked by incubating membranes with 5% skim milk in TBST (10 nmol/L tris--HCl (pH 8.0), 150 mmol/L NaCl, and 0.1% Tween 20) for 1 h at room temperature (rt). Membranes were then incubated with 1:1000 diluted primary antibodies at 4 °C overnight, probed with horseradish peroxidase-conjugated secondary antibodies (1:5000), and visualized by densitometry (ECL system, Amersham, U.K.) according to the manufacturer's instructions.

Cell Cycle Analysis {#sec3.6}
-------------------

Cell cycles were analyzed using a Tali image-based cytometer according to the manufacturer's protocol. HepG2 cells were treated with metallomacrocycle **7** for 24 h. After harvesting, cells were slowly resuspended and incubated overnight with 70% cold ethanol at −20 °C. Moreover, cells were washed with PBS and stained with Tali cell cycle solution for 30 min in the dark. Cell cycles were analyzed using the Tali image-based cytometer.

Statistical Analysis {#sec3.7}
--------------------

Results are presented as the means ± standard errors of means (SEM) of three independent experiments. Statistical analysis was determined by one-way analysis of variance followed by Tukey's multiple comparisons using GraphPad Prism 5.0 (GraphPad, San Diego, California) software. Statistical significance was accepted for *p* values of \<0.05.

### Synthesis of Triazole-Based Ligand **L** {#sec3.7.1}

4-Azidopyridine (11.35 mg, 0.094 mmol), 1,4-bis(ethynyl)anthracene (20.0 mg, 0.043 mmol), CuSO~4~·5H~2~O (0.53 mg, 0.002 mmol) and (+)-sodium [l]{.smallcaps}-ascorbate (0.85 mg, 0.004 mmol) were added to a 4:1 (v/v) solution of *n*-butanol and water and stirred at 50 °C for 24 h. The precipitated product was filtered and washed several times with methanol and water. The light brown powder obtained was characterized as ligand **L**. Yield: (16 mg, yield: 80%), Mp: 307 °C dec. ^1^H NMR (400 MHz, CD~3~OD/CDCl~3~) δ 9.01 (s, 1H), 8.85 (d, *J* = 6.3 Hz, 2H), 8.18 (dd, *J* = 4.7, 1.6 Hz, 2H), 7.90 (dd, *J* = 6.8, 3.2 Hz, 2H), 7.52 (dd, *J* = 6.9, 3.2 Hz, 2H). ^13^C NMR (101 MHz, CD~3~OD:CDCl~3~) δ 151.87, 145.80, 140.24, 134.39, 131.60, 127.40, 126.53, 126.22, 114.88. HR-MS (ESI): calcd for **L** C~28~H~19~N~8~ (L + H^+^) *m*/*z* = 467.1732. Found *m*/*z* = 467.1727. Elemental analysis: calcd (%) for C~28~H~18~N~8~: C, 72.09; H, 3.89; N, 24.02. found: C, 71.80; H, 3.90; N, 23.91.

### Metallomacrocycle **5** {#sec3.7.2}

Arene-Ru(II) acceptor **1** (5.00 mg, 0.008 mmol) and AgCF~3~SO~3~ (5.10 mg, 0.020 mmol) were stirred in CH~3~OH at rt for 6 h. The reaction mixture was filtered to remove AgCl. The filtrate was added with ligand **L** (2.93 mg, 0.008 mmol), and the mixture was stirred rt for 12 h. The product was precipitated with diethyl ether and centrifuged twice. The yellow powder so obtained was dried and characterized as **5**. (9.70 mg, yield: 91%). ^1^H NMR (300 MHz, CD~3~NO~2~) δ 8.60 (s, 1H), 8.39 (d, *J* = 6.9 Hz, 2H), 8.11 (d, *J* = 6.9 Hz, 2H), 7.76 (dd, *J* = 6.8, 3.4 Hz, 2H), 7.05 (dd, *J* = 6.9, 3.2 Hz, 2H), 6.00 (d, *J* = 6.4 Hz, 2H), 5.82 (d, *J* = 6.4 Hz, 2H), 3.01--2.91 (m, 1H), 2.29 (s, 3H), 1.43 (d, *J* = 6.9 Hz, 6H). ^13^C NMR (75 MHz, CD~3~NO~2~) δ 170.86, 154.21, 145.06, 129.48, 125.58, 125.33, 124.43, 123.12, 115.73, 102.96, 98.09, 82.24, 81.33, 31.12, 21.12, 17.00. HR-MS (ESI) for **5** (C~100~H~92~N~16~O~8~Ru~4~): *m*/*z* =512.8365 \[**5**-4OTf\]^4+^. Elemental analysis: calcd (%) for C~104~H~92~F~12~N~16~O~20~Ru~4~S~4~·2H~2~O: C, 46.57; H, 3.61; N, 8.35 found: C, 46.39; H, 3.62; N, 8.33.

### Metallomacrocycle **6** {#sec3.7.3}

Arene-Ru(II) acceptor **2** (5.43 mg, 0.008 mmol) and AgCF~3~SO~3~ (5.10 mg, 0.020 mmol) were stirred in CH~3~OH at rt for 6 h. The reaction mixture was filtered to remove AgCl. The filtrate was added with ligand **L** (2.93 mg, 0.008 mmol), and the mixture was stirred rt for 12 h. The product was precipitated with diethyl ether and centrifuged twice. The brick red powder so obtained was dried and characterized as **6** (9.80 mg, yield: 90%). ^1^H NMR (300 MHz, CD~3~NO~2~) δ 8.79 (s, 1H), 8.63 (d, *J* = 6.9 Hz, 2H), 8.16 (d, *J* = 6.9 Hz, 2H), 7.66 (dd, *J* = 6.9, 3.2 Hz, 2H), 7.04 (dd, *J* = 6.8, 3.2 Hz, 2H), 6.09 (d, *J* = 6.4 Hz, 2H), 5.92 (s, 1H), 5.87 (d, *J* = 6.3 Hz, 2H), 3.03--2.94 (m, 1H), 2.31 (s, 3H), 1.44 (d, *J* = 6.9 Hz, 6H). ^13^C NMR (75 MHz, CD~3~NO~2~) δ 184.53, 154.63, 145.23, 134.63, 130.47, 129.91, 125.54, 121.65, 104.07, 99.27, 83.50, 81.73, 31.26, 21.16, 17.07. (C~109~H~96~F~3~N~16~O~11~Ru~4~S): *m*/*z* =766.7859 \[**6**-3OTf\]^3+^. Elemental analysis: calcd (%) for C~112~H~96~F~12~N~16~O~20~Ru~4~S~4~·2H~2~O: C, 48.34; H, 3.62; N, 8.05. found: C, 48.10; H, 3.63; N, 8.01.

### Metallomacrocycle **7** {#sec3.7.4}

Arene-Ru(II) acceptor **3** (5.83 mg, 0.008 mmol) and AgCF~3~SO~3~ (5.10 mg, 0.020 mmol) were stirred in CH~3~OH at rt for 6 h. The reaction mixture was filtered to remove AgCl. The filtrate was added with ligand **L** (2.93 mg, 0.008 mmol), and the mixture was stirred rt for 12 h. The product was precipitated with diethyl ether and centrifuged twice. The dark green powder so obtained was dried and characterized as **7** (10.60 mg, yield: 93%). ^1^H NMR (300 MHz, CD~3~NO~2~) δ 8.80 (d, *J* = 6.9 Hz, 2H), 8.75 (s, 1H), 8.10 (d, *J* = 6.9 Hz, 2H), 7.67 (dd, *J* = 6.9, 3.2 Hz, 2H), 7.35 (s, 2H), 7.06 (dd, *J* = 6.9, 3.3 Hz, 2H), 5.90 (d, *J* = 6.3 Hz, 2H), 5.69 (d, *J* = 6.3 Hz, 2H), 2.98 (dt, *J* = 13.7, 6.8 Hz, 1H), 2.27 (s, 3H), 1.43 (d, *J* = 6.9 Hz, 6H). ^13^C NMR (75 MHz, CD~3~NO~2~) δ 171.21, 153.84, 145.24, 144.96, 137.30, 130.56, 126.26, 125.69, 123.62, 123.07, 118.83, 115.65, 111.53, 103.73, 99.68, 84.22, 82.84, 30.64, 21.09, 16.17. (C~117~H~100~F~3~N~16~O~11~Ru~4~S): *m*/*z* = 800.1315 \[**7**-3OTf\]^3+^. Elemental analysis: calcd (%) for C~120~H~100~F~12~N~16~O~20~Ru~4~S~4~·2H~2~O: C, 50.31; H, 3.59; N, 7.82. found: C, 49.99; H, 3.66; N, 7.76.

### Metallomacrocycle **8** {#sec3.7.5}

Arene-Ru(II) acceptor **4** (6.63 mg, 0.008 mmol) and AgCF~3~SO~3~ (5.10 mg, 0.020 mmol) were stirred in CH~3~OH at rt for 6 h. The reaction mixture was filtered to remove AgCl. The filtrate was added with ligand **L** (2.93 mg, 0.008 mmol), and the mixture was stirred rt for 12 h. The product was precipitated with diethyl ether and centrifuged twice. The green powder so obtained was dried and characterized as **8** (11.00 mg, yield: 90%). ^1^H NMR (300 MHz, CD~3~NO~2~) δ 8.95 (d, *J* = 6.9 Hz, 2H), 8.86 (dd, *J* = 6.1, 3.3 Hz, 2H), 8.63 (s, 1H), 8.06--7.98 (m, 4H), 7.58 (dd, *J* = 6.9, 3.2 Hz, 2H), 7.00 (dd, *J* = 6.8, 3.3 Hz, 2H), 6.07 (d, *J* = 6.3 Hz, 2H), 5.87 (d, *J* = 6.3 Hz, 2H), 3.19--3.05 (m, 1H), 2.37 (s, 3H), 1.45 (d, *J* = 6.9 Hz, 6H). ^13^C NMR (75 MHz, CD~3~NO~2~) δ 169.50, 153.75, 145.16, 144.83, 133.77, 132.94, 130.46, 127.13, 126.17, 125.59, 123.54, 118.83, 115.68, 107.20, 103.77, 99.79, 83.97, 82.40, 30.66, 21.26, 16.73. (C~133~H~108~F~3~N~16~O~11~Ru~4~S): *m*/*z* = 866.8103 \[**8**-3OTf\]^3+^. Elemental analysis: calcd (%) for C~136~H~110~F~12~N~16~O~21~Ru~4~S~4~·2H~2~O: C, 52.98; H, 3.66; N, 7.27. found: C, 52.86; H, 3.67; N, 7.27.

Conclusions {#sec4}
===========

We report the synthesis of click ligands incorporating the 4-pyridyl-1,2,3-triazole moiety and their coordination-driven self-assembly using arene-Ru(II) acceptors to form cytotoxic metallomacrocycles **5**--**8**. All of the compounds were characterized by ^1^H NMR, ^13^C NMR, ESI-MS, and elemental analysis, and the molecular structure of macrocycle **8** was determined by single-crystal X-ray diffraction. Metallomacrocycle **7** inhibited the growth of A549, AGS, HCT-15, and HepG2 more effectively than doxorubicin, which suggests its potential use as the basis of anticancer drug development. Metallomacrocycle **7** was found to be cytotoxic to HepG2 human hepatocellular carcinoma cells, and this is achieved by inducing apoptosis through activating the extrinsic cell death pathway. Because high levels of p27 can cause S phase arrest by preventing the activation of cyclin E/cdk2, we suggest this might explain HepG2 cell cycle arrest in the S phase after metallomacrocycle **7** exposure. The cytotoxic properties of **3** originates from the presence of 5,8-dihydroxy-1,4-napththoquinone^[@ref44]^ with the arene-Ru(II) moiety, which is enhanced in the metallomacrocycle **7** due to increased nuclearity and the synergistic effect of the ligand containing an anthracene-attached 4-pyridyl-1,2,3-triazole moiety.
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